|
140
|
465
|
4wnwA |
Human cytochrome p450 2d6 thioridazine complex |
|
63
|
188
|
4wf4A |
Crystal structure of e.coli dsba co-crystallised in complex with compound 4 |
|
118
|
315
|
4wduA |
17beta-hsd5 in complex with 4-chloro-n-(4-chlorobenzyl)-5-nitro-1h-pyrazole-3-carboxamide |
|
132
|
376
|
4rx0A |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm265 |
|
148
|
443
|
4u3fA |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
136
|
421
|
4u3fB |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
145
|
379
|
4u3fC |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
137
|
365
|
4rr4A |
Crystal structure of human dihydroorotate dehydrogenase (dhodh) with dh03a367 |
|
16
|
80
|
4u3fG |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
22
|
68
|
4u3fH |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
68
|
241
|
4u3fD |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
22
|
61
|
4u3fJ |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
0
|
47
|
4u3fI |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
39
|
196
|
4u3fE |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
39
|
101
|
4u3fF |
Cytochrome bc1 complex from chicken with designed inhibitor bound |
|
41
|
157
|
4tu5X |
Staphylococcus aureus dihydrofolate reductase complexed with nadph and 6-ethyl-5-[(3s)-3-[3-methoxy-5-(pyridin-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (ucp1062) |
|
109
|
316
|
4qx4A |
Human aldose reductase complexed with a ligand with a new scaffold at 1.26 a |
|
94
|
357
|
4qm1A |
Crystal structure of the inosine 5'-monophosphate dehydrogenase with an internal deletion of the cbs domain from bacillus anthracis str. ames complexed with inhibitor d67 |
|
56
|
206
|
4qjzD |
Pneumocystis carinii dihydrofolate reductase ternary complex with nadph and the inhibitor 24, (n~6~-methyl-n~6~-(naphthalen-1-yl)pyrido[2,3-d]pyrimidine-2,4,6-triamine) |
|
107
|
316
|
4qr6A |
Human aldose reductase complexed with a ligand with an idd structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 a |
|
108
|
316
|
4qbxA |
Human aldose reductase complexed with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 a |
|
93
|
336
|
4qfdA |
Co-crystal structure of compound 2 (3-(7-hydroxy-2-oxo-4-phenyl-2h-chromen-6-yl)propanoic acid) and fad bound to human daao at 2.85a |
|
103
|
356
|
4qj1A |
Co-crystal structure of the catalytic domain of the inosine monophosphate dehydrogenase from cryptosporidium parvum with inhibitor n109 |
|
108
|
314
|
4rpqA |
Human aldose reductase complexed with a ligand with an idd structure at 1.20 a (1) |
|
129
|
350
|
4rliA |
Crystal structure of human dihydroorotate dehydrogenase (dhodh) with dh03a048 |
|
109
|
332
|
4qt0A |
Crystal structure of human muscle l-lactate dehydrogenase in complex with inhibitor 1, 3-{[3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl]amino}benzoic acid |
|
100
|
365
|
4qdfB |
Crystal structure of apo ksha5 and ksha1 in complex with 1,4-30q-coa from r. rhodochrous |
|
54
|
186
|
4qhvA |
Crystal structure of human dihydrofolate reductase as complex with pyridopyrimidine 22 (n~6~-methyl-n~6~-[4-(propan-2-yl)phenyl]pyrido[2,3-d]pyrimidine-2,4,6-triamine) |
|
146
|
477
|
4qhoA |
Crystal structure of an oxygenase in complex with inhibitor cco010 |
|
139
|
365
|
4rk8A |
Crystal structure of human dihydroorotate dehydrogenase (dhodh) with dh03a356 |
|
111
|
332
|
4qsmA |
Crystal structure of human muscle l-lactate dehydrogenase in complex with inhibitor 2, 3-{[7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl]amino}benzoic acid |
|
137
|
365
|
4rkaA |
Crystal structure of human dihydroorotate dehydrogenase (dhodh) with dh03a347 |
|
119
|
331
|
4qo8A |
Lactate dehydrogenase a in complex with substituted 3-hydroxy-2-mercaptocyclohex-2-enone compound 104 |
|
102
|
295
|
4q9nA |
Crystal structure of chlamydia trachomatis enoyl-acp reductase (fabi) in complex with nadh and afn-1252 |
|
41
|
167
|
4qi9A |
Crystal structure of dihydrofolate reductase from yersinia pestis complexed with methotrexate |
|
50
|
186
|
4qjcA |
Human dihydrofolate reductase ternary complex with nadph and inhibitor 26 (n~6~-methyl-n~6~-(3,4,5-trifluorophenyl)pyrido[2,3-d]pyrimidine-2,4,6-triamine) |
|
156
|
476
|
4qknA |
Crystal structure of fto bound to a selective inhibitor |
|
114
|
331
|
4qo7A |
Lactate dehydrogenase a in complex with substituted 3-hydroxy-2-mercaptocyclohex-2-enone compound 7 |
|
100
|
268
|
4qxmA |
Crystal structure of the inha:gsk_sb713 complex |
|
109
|
315
|
4pr4A |
Human aldose reductase complexed with schl7802 at 1.06 a |
|
111
|
316
|
4prtA |
Human aldose reductase complexed with schl12221 ({2-[5-(3-nitrophenyl)furan-2-yl]phenyl}acetic acid) at 0.96 a |
|
112
|
315
|
4prrA |
Human aldose reductase complexed with schl7815 ((3-[3-(5-nitrofuran-2-yl)phenyl]propanoic acid)at 1.01 a |
|
107
|
316
|
4puwA |
Human aldose reductase complexed with a ligand with an idd structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 a |
|
107
|
316
|
4puuA |
Human aldose reductase complexed with a ligand with an idd structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 a |
|
123
|
454
|
4p8hA |
Crystal structure of m. tuberculosis dpre1 in complex with the nitro-benzothiazole 6a |
|
144
|
456
|
4p8pA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor qn127 |
|
147
|
458
|
4p8nA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor qn118 |
|
137
|
457
|
4p8kA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor ty38c |
|
131
|
454
|
4pfaA |
Crystal structure of m. tuberculosis in complex with bto - covalent adduct |
|
138
|
455
|
4pfdA |
Crystal structure of m. tuberculosis in complex with a cbt - non-covalent adduct |
